WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009058801) USE OF CFMS INHIBITOR FOR TREATING OR PREVENTING BONE CANCER AND THE BONE LOSS AND BONE PAIN ASSOCIATED WITH BONE CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/058801    International Application No.:    PCT/US2008/081501
Publication Date: 07.05.2009 International Filing Date: 29.10.2008
IPC:
A61K 31/4439 (2006.01), A61P 35/04 (2006.01)
Applicants: JANSSEN PHARMACEUTICA, N.V. [BE/BE]; Turnhoutseweg 30 B-2340 Beerse (BE) (For All Designated States Except US).
MANTHEY, Carl L. [US/US]; (US) (For US Only)
Inventors: MANTHEY, Carl L.; (US)
Agent: APPOLLINA, Mary A.; One Johnson & Johnson Plaza New Brunswick, New Jersey 08933 (US)
Priority Data:
60/984,978 02.11.2007 US
Title (EN) USE OF CFMS INHIBITOR FOR TREATING OR PREVENTING BONE CANCER AND THE BONE LOSS AND BONE PAIN ASSOCIATED WITH BONE CANCER
(FR) UTILISATION D'INHIBITEUR CFMS POUR LE TRAITEMENT OU LA PRÉVENTION DU CANCER DES OS ET DE LA PERTE OSSEUSE ET DE LA DOULEUR OSSEUSE ASSOCIÉES AU CANCER DES OS
Abstract: front page image
(EN)The present invention provides therapeutic methods for treating a subject having, and prophylactic methods for preventing in a subject at risk of (or susceptible to ) developing, bone cancer and the bone loss and bone pain associtated with bone cancer, said method comprising the administration of a compound of Formula (I), or a solvate, hydrate, tautomer or pharmaceutically acceptable salt thereof.
(FR)L'invention concerne des procédés thérapeutiques pour traiter un sujet présentant un risque (ou susceptible) de développer un cancer des os et des procédés prophylactiques pour empêcher un sujet de développer un cancer des os, ainsi que pour traiter la perte osseuse et la douleur osseuse associées au cancer des os, ledit procédé comprenant l'administration d'un composé de formule I ou d'un solvate, d'un hydrate, d'un tautomère ou d'un sel pharmaceutiquement acceptable de celui-ci.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)